MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO)
source: myfinsight.com
Download
Download image
Net comprehensive
loss
-$43,059,000
(27.75%↑ Y/Y)
Interest and other
income, net
$3,573,000
(-35.22%↓ Y/Y)
Other income
(expenses), net
$212,000
(130.43%↑ Y/Y)
Net loss
-$42,607,000
(28.67%↑ Y/Y)
Net unrealized gain
(loss) on...
-$452,000
(-442.42%↓ Y/Y)
Total other income
(expenses), net
$3,485,000
(-36.15%↓ Y/Y)
Interest expense
$300,000
(100.00%↑ Y/Y)
Loss from operations
-$46,092,000
(29.30%↑ Y/Y)
Total operating
expenses
$46,092,000
(-29.30%↓ Y/Y)
Research and development
$32,003,000
(-36.25%↓ Y/Y)
General and
administrative
$14,089,000
(-6.02%↓ Y/Y)
Back